Literature DB >> 24933167

The endocannabinoid system and appetite: relevance for food reward.

Gerry Jager1, Renger F Witkamp1.   

Abstract

Mounting evidence substantiates the central role of the endocannabinoid system (ECS) in the modulation of both homeostatic and hedonic elements of appetite and food intake. Conversely, feeding status and dietary patterns directly influence activity of the ECS. Following a general introduction on the functioning of the ECS, the present review specifically addresses its role in the modulation of hedonic eating. Humans possess strong motivational systems triggered by rewarding aspects of food. Food reward is comprised of two components: one appetitive (orienting towards food); the other consummatory (hedonic evaluation), also referred to as 'wanting' and 'liking', respectively. Endocannabinoid tone seems to influence both the motivation to feed and the hedonic value of foods, probably by modifying palatability. Human physiology underlying hedonic eating is still not fully understood. A better understanding of the role of the ECS in the rewarding value of specific foods or diets could offer new possibilities to optimise the balance between energy and nutrient intake for different target groups. These groups include the obese and overweight, and potentially individuals suffering from malnutrition. Examples for the latter group are patients with disease-related anorexia, as well as the growing population of frail elderly suffering from persistent loss of food enjoyment and appetite resulting in malnutrition and involuntary weight loss. It has become clear that the psychobiology of food hedonics is extremely complex and the clinical failure of CB1 inverse agonists including rimonabant (Accomplia®) has shown that 'quick wins' in this field are unlikely.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24933167     DOI: 10.1017/S0954422414000080

Source DB:  PubMed          Journal:  Nutr Res Rev        ISSN: 0954-4224            Impact factor:   7.800


  31 in total

1.  Cannabinoid CB1 receptor inhibition blunts adolescent-typical increased binge alcohol and sucrose consumption in male C57BL/6J mice.

Authors:  Abigail E Agoglia; Sarah E Holstein; Vallari R Eastman; Clyde W Hodge
Journal:  Pharmacol Biochem Behav       Date:  2016-01-19       Impact factor: 3.533

2.  Effects of co-administration of 2-arachidonylglycerol (2-AG) and a selective µ-opioid receptor agonist into the nucleus accumbens on high-fat feeding behaviors in the rat.

Authors:  Kyle E Parker; Jordan G McCall; Sophia R McGuirk; Seema Trivedi; Dennis K Miller; Matthew J Will
Journal:  Brain Res       Date:  2015-06-19       Impact factor: 3.252

3.  Oral health implications of increased cannabis use among older adults: Another public health concern?

Authors:  Austin Le; Joseph J Palamar
Journal:  J Subst Use       Date:  2018-08-22

Review 4.  Metabolism disrupting chemicals and metabolic disorders.

Authors:  Jerrold J Heindel; Bruce Blumberg; Mathew Cave; Ronit Machtinger; Alberto Mantovani; Michelle A Mendez; Angel Nadal; Paola Palanza; Giancarlo Panzica; Robert Sargis; Laura N Vandenberg; Frederick Vom Saal
Journal:  Reprod Toxicol       Date:  2016-10-17       Impact factor: 3.143

5.  Cannabinoid CB1 /CB2 receptor agonists attenuate hyperactivity and body weight loss in a rat model of activity-based anorexia.

Authors:  Maria Scherma; Valentina Satta; Roberto Collu; Maria Francesca Boi; Paolo Usai; Walter Fratta; Paola Fadda
Journal:  Br J Pharmacol       Date:  2017-07-11       Impact factor: 8.739

6.  Environmental Obesogens: Mechanisms and Controversies.

Authors:  Jerrold J Heindel; Bruce Blumberg
Journal:  Annu Rev Pharmacol Toxicol       Date:  2018-07-25       Impact factor: 13.820

Review 7.  Role of the Endocannabinoid System in the Pathophysiology of Schizophrenia.

Authors:  Marc Fakhoury
Journal:  Mol Neurobiol       Date:  2016-01-15       Impact factor: 5.590

8.  Neural activation patterns underlying basolateral amygdala influence on intra-accumbens opioid-driven consummatory versus appetitive high-fat feeding behaviors in the rat.

Authors:  Kyle E Parker; Matt P McCabe; Howard W Johns; Dane K Lund; Fiona Odu; Rishi Sharma; Mahesh M Thakkar; D D W Cornelison; Matthew J Will
Journal:  Behav Neurosci       Date:  2015-10-26       Impact factor: 1.912

Review 9.  Translational models of cannabinoid vapor exposure in laboratory animals.

Authors:  Catherine F Moore; Jeffrey W Stiltner; Catherine M Davis; Elise M Weerts
Journal:  Behav Pharmacol       Date:  2022-04-01       Impact factor: 2.293

10.  Appetitive, antinociceptive, and hypothermic effects of vaped and injected Δ-9-tetrahydrocannabinol (THC) in rats: exposure and dose-effect comparisons by strain and sex.

Authors:  Catherine F Moore; Catherine M Davis; Eric L Harvey; Michael A Taffe; Elise M Weerts
Journal:  Pharmacol Biochem Behav       Date:  2021-01-23       Impact factor: 3.533

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.